Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

February 01, 2016

The Business of Immuno-Oncology

Big Innovation and Big Deals Characterize the Era of Immunotherapeutics

The Business of Immuno-Oncology

Figure 1. Number of open clinical trials in Phase I for different cancers.

Much has happened since American surgeon and cancer researcher William Colley made the first observations that gave rise to the field of tumor immunology That was in the 1890s, and the following century has been extremely fruitful in terms of our increased understanding of the molecular basis of immune responses ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content